Seeing Is Believing
with an average price target of $1.64. This is a potential upside of $1.64 (0%) from yesterday's end of day stock price of $0.
Prevail Therapeutics's activity chart (see below) currently has 16 price targets and 14 ratings on display.
Analysts average stock forecasts to be materialized ratio is 68% with an average time for these price targets to be met of 199.2 days.
Most recent stock forecast was given by LAURA CHICO from WEDBUSH on 23-Dec-2020. First documented stock forecast 15-Jul-2019.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$22
$-1 (-4.35%)
$22
4 years 11 months 23 days ago
(23-Dec-2020)
2/5 (40%)
$-1.18 (-5.09%)
234
Hold
$23
$23
4 years 11 months 29 days ago
(17-Dec-2020)
2/2 (100%)
$-0.17 (-0.73%)
84
Hold
$24
$1 (4.35%)
$24
5 years 1 days ago
(15-Dec-2020)
0/2 (0%)
$1.25 (5.49%)
Buy
5 years 4 months 5 days ago
(11-Aug-2020)
2/2 (100%)
$4.12 (25.94%)
241
Buy
$20
$-3 (-13.04%)
$20
5 years 11 months 19 days ago
(27-Dec-2019)
2/2 (100%)
$4.19 (26.50%)
437
What is PRVL (Prevail Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on PRVL (Prevail Therapeutics) with a proven track record?
Which analyst has the current lower performing score on PRVL (Prevail Therapeutics) with a proven track record?
Which analyst has the most public recommendations on PRVL (Prevail Therapeutics)?
Which analyst is the currently most bullish on PRVL (Prevail Therapeutics)?
Which analyst is the currently most reserved on PRVL (Prevail Therapeutics)?